Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 2:06 AM ET

Healthcare Equipment and Supplies

Company Overview of 480 Biomedical, Inc.

Company Overview

480 Biomedical, Inc. focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown, Massachusetts.

480 Arsenal Street

Watertown, MA 02172

United States

Founded in 2011



Key Executives for 480 Biomedical, Inc.

Chief Executive Officer and Member of The Board of Directors
Age: 68
Co-Founder and Chairman of The Board
Co-Founder and Member of The Board of Directors
Age: 76
Co-Founder and Member of The Board of Directors
Age: 67
Vice President of Operations
Compensation as of Fiscal Year 2015.

480 Biomedical, Inc. Key Developments

480 Biomedical, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:20 PM

480 Biomedical, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:20 PM. Venue: Westin Grand Central, New York, New York, United States.

480 Biomedical Wins $1 Million Phase II Nhlbi Contract to Advance Bioresorbable Scaffold for Pediatric Pulmonary Artery Stenosis

480 Biomedical, Inc. announced that it has been awarded Phase II funding from the National Heart, Lung, and Blood Institute to continue the development of a bioresorbable, self-expanding scaffold to treat pediatric pulmonary artery stenosis. The product aims to address the serious challenges in treating cardiovascular stenosis in children with growing blood vessels. The scaffold's unique design has the strength of a balloon-expandable metal stent to keep vessels open for an extended period before safely resorbing. The scaffold can also be delivered through a small catheter, which is essential for treating a pediatric population. This latest $1 million round of funding will be used to further refine the design of the product and conduct preclinical testing.

Similar Private Companies By Industry

Company Name Region
ActivaDerm, Inc. United States
Veritract, Inc. United States
Johnson's Orthopedic Designs, Inc. United States
InBios International, Inc. United States
Incept BioSystems, Inc. United States

Recent Private Companies Transactions

Private Placement
June 1, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact 480 Biomedical, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at